Showing results 1 to 4 of 4
| Title | Author(s) | Issue Date | |
|---|---|---|---|
76 week follow up of HBeAg-positive chronic hepatitis B patients treated with telbivudine, adefovir or switched from adefovir to telbivudine Proceeding/Conference:Journal of Hepatology | 2007 | ||
In hepatitis B patients treated with either adefovir or telbivudine, maximal early hbv suppression at 24 weeks predicts optimal one-year efficacy Proceeding/Conference:Journal of Hepatology | 2007 | ||
A Randomized Trial of Telbivudine (LdT) vs Adefovir for HBeAg-positive Chronic Hepatitis B: Final Week 52 results Proceeding/Conference:Hepatology | 2006 | ||
Treatment of hepatitis B e antigen-positive chronic hepatitis with telbivudine or adefovir: A randomized trial Journal:Annals of Internal Medicine | 2007 |